Triastek Announces Research Collaboration with Lilly to Explore the Application of 3D Printing Technology in Oral Delivery of Drugs
On July 13, 2022, Triastek, Inc. (“Triastek”) announced a collaboration with Eli Lilly and Company (“Lilly”), a leading global pharmaceutical company, to leverage the advantages of 3D printing technology to enable precisely targeted and...
Recent Comments